HAP Trading’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,500
Closed -$362K 1227
2023
Q2
$362K Buy
+8,500
New +$6.55M 0.06% 221
2022
Q1
Sell
-35,500
Closed -$286K 2673
2021
Q4
$286K Buy
35,500
+13,900
+64% +$8.55M 0.01% 887
2021
Q3
$156K Sell
21,600
-2,300
-10% -$1.43M 0.01% 1120
2021
Q2
$201K Sell
23,900
-5,000
-17% -$2.53M 0.01% 1013
2021
Q1
$441K Sell
28,900
-8,400
-23% -$4.09M 0.02% 527
2020
Q4
$478K Buy
37,300
+20,300
+119% +$11M 0.01% 649
2020
Q3
$207K Buy
+17,000
New +$10.3M 0.01% 627
2019
Q1
Sell
-11,200
Closed -$220K 1329
2018
Q4
$220K Buy
11,200
+700
+7% +$256K 0.01% 528
2018
Q3
$137K Sell
10,500
-1,500
-13% -$571K 0.01% 504
2018
Q2
$72K Buy
+12,000
New +$3.75M ﹤0.01% 617
2017
Q2
Sell
-18,600
Closed -$109K 1133
2017
Q1
$109K Buy
+18,600
New +$6.89M 0.01% 560
2016
Q4
Sell
-16,500
Closed -$307K 1179
2016
Q3
$307K Buy
16,500
+6,000
+57% +$2.41M 0.01% 433
2016
Q2
$339K Buy
+10,500
New +$4.04M 0.02% 367

Other funds holding REGN